~~<i id='2C79C55469'><strike id='2C79C55469'><tt id='2C79C55469'><pre id='2C79C55469'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：focus 2025-10-02 00:42:49 - browse：64

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Sweden knocks USA out of World Cup in penalty kicks

focus

explore

hotspot

Wikipedia

hotspot

DANVILLE,Pa.--APennsylvaniamansayshe'spayingalotmoreattentiontohissurroundingsafterasurpriseatt

WSS

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Many breast cancer patients receive more radiation than needed

Trump used to be more articulate. What could explain the change?

Doctors push to include dialysis machines in emergency stockpile

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

FDA's Woodcock to retire early next year

leisure time

focus

focus

Virginia high school admissions case could be legal follow

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

BioMarin wins approval for gene therapy to treat hemophilia A

Congress must reauthorize a committee to support older Americans

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Weight loss drug costs may need more research, senator suggests

Supreme Court strikes down use of affirmative action

'Brian's Song' at 50 still offers lessons about cancer for today

Continuity nursing helped my family in our darkest PICU moments

Does good food count as health care? Study aims to find out

focus

Sage considers ways to reduce costs following FDA rejection

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

NYU radiologists take on the challenge of expensive MRI machines

Kansas bar where gunfire wounded 9 last month closes permanently

Feed a cold, starve a fever? Here’s what science says

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

explore

hotspot

Wikipedia

hotspot